Market Overview:
The global botulinum toxin fillers market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of muscle movement disorders, urinary tract conditions, and excessive sweating. Additionally, the growing demand for minimally invasive procedures and rising awareness about the benefits of botulinum toxin fillers are also contributing to the growth of this market. The therapeutic botulinum toxin segment is expected to dominate the global botulinum toxin fillers market in terms of revenue during the forecast period. This segment accounted for a majority share of the global market in 2017 and is projected to maintain its dominance during the forecast period owing to its high usage rates for treating muscle movement disorders such as spasticity and dystonia.
Product Definition:
Botulinum toxin fillers are a category of medical treatments used to improve the appearance of wrinkles and lines on the face. Botulinum toxin is a neurotoxin that is produced by bacteria. When injected into the skin, it blocks nerve signals to muscles, which causes them to relax and reduces the appearance of wrinkles and lines. Botulinum toxin fillers are generally considered safe and effective treatments for reducing the signs of aging.
Therapeutic Botulinum Toxin:
The therapeutic botulinum toxin, also known as BNT or Botox is a neurotoxin produced by an anaerobic bacterium, Clostridium botulinum. It has potent anti-inflammatory and analgesic effects and blocks release of both acetylcholine (ACh) and serotonin in the brain.
Aesthetic Botulinum Toxin:
Aesthetic Botulinum Toxin is also known as BNT or just Botox. It is a neurotoxin which prevents the release of acetylcholine by the cholinergic nerve terminals and blocks the muscles from moving. Aesthetic botulinum toxin has been used in cosmetic surgeries to reduce wrinkles, prevent age-related muscle loss, improve skin tone, and enhance elastin & collagen production for improving aesthetic appearance.
Application Insights:
Botulinum toxin is used for various applications including muscle movement disorder, excessive sweating, chronic migraine headache, and urinary tract conditions. In 2017, the others segment dominated the market with a share of over 40% in terms of revenue. The muscle movement disorder segment held a significant share in 2017 owing to increasing incidences of spasticity and hyperactivity disorders among children which requires botulinum toxin injection into muscles as it reduces excessive movements.
The chronic migraine headache application is expected to witness the fastest growth rate from 2018 to 2030 due to high demand for effective treatment alternatives that do not involve surgery or other invasive procedures. According to Migraine Research Foundation International Inc., around 1 out of 5 people suffer from migraines globally; however only 1-2% receive proper diagnosis & treatment due to lack of awareness about this disease coupled with financial constraints restraining patients from seeking expensive treatments outside their reach.
Regional Analysis:
North America dominated the global market in 2017 owing to the rising prevalence of chronic conditions, such as arthritis and diabetes, increasing awareness about aesthetic procedures among people, and availability of a large patient pool. Moreover, high disposable income is anticipated to fuel demand for cosmetic products in this region. In addition, presence of key players is also expected to drive growth over the forecast period.
Asia Pacific market for botulinum toxin fillers is expected to grow at a lucrative rate over the forecast period due to factors such as growing medical tourism industry and improving healthcare facilities resulting into an increase in consumer disposable income levels which will result into increased demand for therapeutic Botox treatments among individuals from developing countries like India & China & South Korea etc.). In addition, growing number of dermatology clinics/surgeons coupled with rising awareness about aesthetic procedures are some other factors that can be attributed towards regional growth during the forecast years. FurthermoreBotox Australia Pty Ltd.
Growth Factors:
- Increasing demand for minimally invasive procedures: The global Botulinum Toxin Fillers market is witnessing a shift towards minimally invasive procedures, which is driving the growth of the market.
- Rising prevalence of facial wrinkles and aging population: The increasing prevalence of facial wrinkles and aging population is propelling the growth of the Botulinum Toxin Fillers market.
- Growing awareness about aesthetic treatments: There is a growing awareness about aesthetic treatments among people, which is fueling the demand for Botulinum Toxin Fillers products globally.
- Technological advancements in Botulinum Toxin Fillers products: The technological advancements in Botulinum Toxin Fillers products are helping to improve their efficacy and safety, thus driving their adoption worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Botulinum Toxin Fillers Market Research Report
By Type
Therapeutic Botulinum Toxin, Aesthetic Botulinum Toxin
By Application
Muscle Movement Disorder, Urinary Tract Conditions, Excessive Sweating, Chronic Migraine Headache, Others
By Companies
Allergan PLC, Medytoc Solutions Inc, Ipsen, Merz Pharma Gmbh, US Worldmed, LLC, Lanzhou Institution of Biological Products Co., Ltd., Revance Therapeutics, Inc, Allergan PLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Botulinum Toxin Fillers Market Report Segments:
The global Botulinum Toxin Fillers market is segmented on the basis of:
Types
Therapeutic Botulinum Toxin, Aesthetic Botulinum Toxin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Muscle Movement Disorder, Urinary Tract Conditions, Excessive Sweating, Chronic Migraine Headache, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan PLC
- Medytoc Solutions Inc
- Ipsen
- Merz Pharma Gmbh
- US Worldmed, LLC
- Lanzhou Institution of Biological Products Co., Ltd.
- Revance Therapeutics, Inc
- Allergan PLC
Highlights of The Botulinum Toxin Fillers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Therapeutic Botulinum Toxin
- Aesthetic Botulinum Toxin
- By Application:
- Muscle Movement Disorder
- Urinary Tract Conditions
- Excessive Sweating
- Chronic Migraine Headache
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Botulinum Toxin Fillers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Botulinum toxin fillers are a type of injectable cosmetic treatment that use botulinum toxin to reduce wrinkles, lines, and other signs of aging. Botulinum toxin is a neurotoxin that can cause muscle paralysis. This injection procedure uses small amounts of botulinum toxin to relax the muscles in your face, which can improve your appearance.
Some of the major companies in the botulinum toxin fillers market are Allergan PLC, Medytoc Solutions Inc, Ipsen, Merz Pharma Gmbh, US Worldmed, LLC, Lanzhou Institution of Biological Products Co., Ltd., Revance Therapeutics, Inc, Allergan PLC.
The botulinum toxin fillers market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Botulinum Toxin Fillers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Botulinum Toxin Fillers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Botulinum Toxin Fillers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Botulinum Toxin Fillers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Botulinum Toxin Fillers Market Size & Forecast, 2020-2028
4.5.1 Botulinum Toxin Fillers Market Size and Y-o-Y Growth
4.5.2 Botulinum Toxin Fillers Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Therapeutic Botulinum Toxin
5.2.2 Aesthetic Botulinum Toxin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Muscle Movement Disorder
6.2.2 Urinary Tract Conditions
6.2.3 Excessive Sweating
6.2.4 Chronic Migraine Headache
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Botulinum Toxin Fillers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Botulinum Toxin Fillers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Therapeutic Botulinum Toxin
9.6.2 Aesthetic Botulinum Toxin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Muscle Movement Disorder
9.10.2 Urinary Tract Conditions
9.10.3 Excessive Sweating
9.10.4 Chronic Migraine Headache
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Therapeutic Botulinum Toxin
10.6.2 Aesthetic Botulinum Toxin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Muscle Movement Disorder
10.10.2 Urinary Tract Conditions
10.10.3 Excessive Sweating
10.10.4 Chronic Migraine Headache
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Therapeutic Botulinum Toxin
11.6.2 Aesthetic Botulinum Toxin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Muscle Movement Disorder
11.10.2 Urinary Tract Conditions
11.10.3 Excessive Sweating
11.10.4 Chronic Migraine Headache
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Therapeutic Botulinum Toxin
12.6.2 Aesthetic Botulinum Toxin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Muscle Movement Disorder
12.10.2 Urinary Tract Conditions
12.10.3 Excessive Sweating
12.10.4 Chronic Migraine Headache
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Therapeutic Botulinum Toxin
13.6.2 Aesthetic Botulinum Toxin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Muscle Movement Disorder
13.10.2 Urinary Tract Conditions
13.10.3 Excessive Sweating
13.10.4 Chronic Migraine Headache
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Botulinum Toxin Fillers Market: Competitive Dashboard
14.2 Global Botulinum Toxin Fillers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan PLC
14.3.2 Medytoc Solutions Inc
14.3.3 Ipsen
14.3.4 Merz Pharma Gmbh
14.3.5 US Worldmed, LLC
14.3.6 Lanzhou Institution of Biological Products Co., Ltd.
14.3.7 Revance Therapeutics, Inc
14.3.8 Allergan PLC
